![]() |
市場調查報告書
商品編碼
1954624
測高儀和地形測量系統市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2026-2034 年)Aberrometer and Topography Systems Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球測高儀和地形測量系統市場規模為 5.0124 億美元,預計 2026 年將成長至 5.2838 億美元,到 2034 年將達到 8.3673 億美元。預測期內的複合年增長率預計為 6.61%。預計到2025年,北美將以17.59%的市場佔有率引領市場,這主要歸功於接受眼科手術的患者人數不斷增加以及先進眼科診斷技術的快速普及。
視差計和角膜地形圖系統對現代眼科醫學至關重要。視差計測量眼球內的光學像差,評估光線通過角膜和水晶體折射的缺陷,進而影響視覺品質。角膜地形圖可提供角膜曲率和形狀的詳細圖譜,有助於診斷和治療各種眼部疾病。散光、遠視和白內障等視力障礙的日益普遍推動了對這些先進診斷解決方案的需求。根據美國國家生物技術資訊中心(NCBI)統計,全球40%的成年人患有散光,凸顯了對精準眼科診斷日益增長的需求。
市場動態
驅動因素:生活方式的改變、糖尿病以及因老化導致的眼科疾病盛行率上升是主要的成長驅動因素。預計到2050年,近視將影響全球50%的人口,凸顯了使用波前像差測量設備和地形圖系統進行早期診斷的重要性。各國政府和醫療機構對預防性眼科保健的重視也進一步推動了對診斷設備的需求。
限制因素:先進設備的高昂成本(例如,預計到2025年,Nidek OPD-Scan III波前像差儀的價格將達到約15,000美元)限制了其在發展中地區的普及。此外,中低收入國家對定期眼科檢查的認知不足也阻礙了市場滲透。世界衛生組織的數據顯示,全球有22億人患有視力障礙,其中10億人本可預防,反映出人們對視力障礙的認知存在差距。
機會:主要參與者之間的策略聯盟和收購正在創造市場擴張的機會。例如,卡爾蔡司醫療技術股份公司於2024年4月收購了D.O.R.C.,從而增強了其眼科解決方案組合。合作關係將加速下一代診斷工具的開發,並促進產品創新和新產品上市。
挑戰:訓練有素的眼科專業人員短缺可能會阻礙市場成長。截至2024年,美國祇有不到6萬名眼科技術人員為超過1.9萬名眼科醫生提供支持,這可能會限制患者獲得先進診斷服務的機會。
市場區隔
依類型劃分:市場區隔分為像差儀和地形圖系統。哈特曼-夏克法和光線追蹤等技術創新使像差儀產業佔了領先地位。例如,Tracey Technologies 於 2023 年 2 月推出了 iTrace Prime,增強了其像差儀和角膜地形測量功能。包括 Placido 圓盤法和 Schein-Frug 法在內的角膜地形圖系統也在不斷擴展,透過整合人工智慧和物聯網技術來提高診斷準確性。
依適應症劃分:遠視、近視和散光是該市場的主要適應症。由於遠視在成人(30.9%)和兒童(4.6%)的高發病率,預計遠視將佔較大的市場佔有率。近視的增加是由於螢幕使用時間和人口老化,而散光則受益於能夠提供精確角膜圖的先進角膜地形圖系統,例如 Cassini 角膜地形圖儀。
依最終用戶劃分:醫院由於其手術量大且擁有先進的設備,因此處於領先地位。同時,由於診斷解決方案的日益普及,眼科診所預計將以最高的複合年增長率成長。遠距醫療和學術診所正透過遠距驗光服務的擴展(例如 Visionix 和 20/20NOW 等,預計在 2023 年)成為重要的成長貢獻者。
技術創新正在改變市場格局,包括動態波前像差測量、多模態地形圖以及用於遠距眼科會診的便攜式設備。人工智慧和物聯網的融合正在提升診斷準確性、工作流程效率和個人化患者護理水準。
新冠疫情的影響
由於病患就診量減少和供應鏈中斷,疫情導致需求暫時下降。卡爾蔡司醫療技術股份公司報告稱,2020年銷售額下降了7%。自2021年以來,隨著患者就診量的增加,市場呈現復甦趨勢。
The global aberrometer & topography systems market was valued at USD 501.24 million in 2025 and is projected to grow to USD 528.38 million in 2026, reaching USD 836.73 million by 2034, registering a CAGR of 6.61% during the forecast period. North America led the market in 2025 with a 17.59% share, primarily due to the rising number of individuals undergoing eye surgeries and the rapid adoption of advanced ophthalmic diagnostic technologies.
Aberrometers and corneal topography systems are crucial in modern ophthalmology. An aberrometer measures optical aberrations in the eye, assessing imperfections in light refraction through the cornea and lens, affecting vision quality. Corneal topography provides detailed mapping of corneal curvature and shape, aiding in the diagnosis and management of various ocular conditions. The rising prevalence of visual impairments such as astigmatism, hyperopia, and cataracts has spurred demand for these advanced diagnostic solutions. According to NCBI, astigmatism affects 40% of adults globally, emphasizing the growing need for accurate eye diagnostics.
Market Dynamics
Drivers: The increasing incidence of ophthalmic diseases, driven by lifestyle changes, diabetes, and an aging population, is a major growth driver. Myopia is projected to affect 50% of the global population by 2050, highlighting the importance of early diagnosis using aberrometers and topography systems. Governments and healthcare providers are prioritizing preventive eye care, further boosting demand for diagnostic devices.
Restraints: The high cost of advanced devices, such as the Nidek OPD-Scan III Wavefront Aberrometer priced around USD 15,000 in 2025, limits adoption in developing regions. Additionally, limited awareness regarding routine eye exams in low- and middle-income countries reduces market penetration. WHO data indicates 2.2 billion people worldwide suffer from vision impairment, with 1 billion cases preventable, reflecting the awareness gap.
Opportunities: Strategic alliances and acquisitions among key players are creating opportunities for market expansion. For instance, Carl Zeiss Meditech AG acquired D.O.R.C. in April 2024, enhancing its portfolio of ophthalmic solutions. Partnerships facilitate the development of next-generation diagnostic tools, fueling product innovation and new launches.
Challenges: The shortage of trained ophthalmic professionals could hinder market growth. In the U.S., there were fewer than 60,000 ophthalmic technicians supporting over 19,000 ophthalmologists as of 2024, potentially limiting patient access to advanced diagnostic services.
Market Segmentation
By Type: The market is segmented into aberrometers and topography systems. The aberrometer segment dominates due to innovations like Hartmann-Shack and Ray-Tracing techniques. For example, Tracey Technologies launched iTrace Prime in February 2023, enhancing aberrometer and topographer functionalities. Topography systems, including Placido disc and Scheimpflug imaging, are also expanding with AI and IoT integration for improved diagnostics.
By Indication: Hyperopia, myopia, astigmatism, and others form the market indications. Hyperopia is projected to hold a significant share due to its prevalence in adults (30.9%) and children (4.6%). Myopia growth is driven by screen time and aging populations, while astigmatism benefits from advanced topography systems, such as the Cassini topographer, providing accurate corneal maps.
By End-User: Hospitals lead due to higher procedural volumes and access to advanced equipment, while ophthalmic clinics are projected to grow at the highest CAGR due to increasing availability of diagnostic solutions. Telehealth and academic clinics are emerging as significant contributors through strategic partnerships, such as Visionix and 20/20NOW in 2023, expanding tele-optometry services.
Competitive Landscape
The market is consolidated with Carl Zeiss Meditech AG, Topcon Corporation, and Alcon Inc. holding the majority share. Companies focus on strategic alliances, acquisitions, and new product launches to expand their global presence. Other key players include NIDEK, Haag-Streit Group, EssilorLuxottica, Rexxam, Schwind eye-tech, and Mediworks. Notable developments include EssilorLuxottica acquiring 80% of Heidelberg Engineering in 2024 and Haag-Streit Japan K.K. launch in 2023.
Market Trends
Technological advancements are transforming the market, including dynamic wavefront aberrometry, multimodal topography, and portable devices for remote eye care. AI and IoT integration enhance diagnostic precision, workflow efficiency, and personalized patient care.
COVID-19 Impact
The pandemic caused a temporary decline in demand due to reduced patient visits and supply chain disruptions. Carl Zeiss Meditech AG reported a -7% sales decline in 2020. Post-2021, market recovery has been observed as patient visits increased.
Conclusion
The global aberrometer & topography systems market is poised for substantial growth from USD 501.24 million in 2025 to USD 836.73 million by 2034, driven by technological innovations, increasing prevalence of eye disorders, and strategic initiatives by market leaders. Despite challenges such as high device costs and skilled workforce shortages, the market presents significant opportunities across all regions, particularly in Asia Pacific, telehealth, and advanced diagnostic solutions.
Segmentation By Type
By Indication
By End-user
By Geography